Hackensack University Medical Center Collaborates With Diabetes Researcher to Test New Treatment

Hackensack (N.J.) University Medical Center has collaborated with Camillo Ricordi, MD, scientific director and chief academy officer of the University of Miami Diabetes Research Institute, to test a new treatment for diabetes, according to a Record report.

Advertisement

HUMC will be the first facility to try the procedure on humans, as so far the tests have been limited to monkeys. Dr. Ricordi’s technique includes loading islets — the cells that make insulin and are destroyed by Type 1 diabetes — on a disc and implanting them in the abdomen. In the past, islets have been transplanted in the liver with little success.

Because of promising results with the monkeys, Michael Shapiro, MD, HUMC’s chief of organ transplantation and leader of the diabetes partnership, hopes to have four patients undergo the procedure in early 2012.

Read the Record report on Hackensack University Medical Center’s diabetes research.

Read more coverage on Hackensack University Medical Center:

– Hackensack University Medical Center Opens Heart and Vascular Hospital

– New Jersey’s Valley, Englewood Hospitals Fight Reopening of Pascack Valley Hospital

– New Jersey Health Department to Accept Applications for New Hospital in Bergen County, Moving Hackensack Plans Forward

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Care Coordination

Advertisement

Comments are closed.